Security key
03753U106
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)
CUSIP: 03753U106
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 127,672,507
- Total 13F shares
- 32,104,592
- Share change
- -1,623,636
- Total reported value
- $423,490,077
- Price per share
- $13.19
- Number of holders
- 95
- Value change
- -$27,345,727
- Number of buys
- 57
- Number of sells
- 35
Report period
Q4 2018
Institutions
95
Top holders
10
APLS full security history
Newer quarter: Q1 2019
Previous quarter: Q3 2018
Apellis Pharmaceuticals, Inc. SEC filings
Apellis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03753U106
Recent filing periods:
Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. |
13F
|
Company |
3.4%
|
4,328,289
|
$76,957,000 | — | 30 Sep 2018 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.3%
|
4,172,498
|
$74,187,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
2,853,195
|
$50,730,000 | — | 30 Sep 2018 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
1.6%
|
2,038,516
|
$36,245,000 | — | 30 Sep 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,414,900
|
$25,157,000 | — | 30 Sep 2018 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,364,265
|
$24,258,000 | — | 30 Sep 2018 | |
| Vivo Capital, LLC |
13F
|
Company |
1.1%
|
1,354,554
|
$24,084,000 | — | 30 Sep 2018 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,347,753
|
$23,963,000 | — | 30 Sep 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.87%
|
1,107,109
|
$19,684,000 | — | 30 Sep 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.71%
|
910,559
|
$16,190,000 | — | 30 Sep 2018 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.7%
|
900,000
|
$16,002,000 | — | 30 Sep 2018 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.48%
|
612,296
|
$10,887,000 | — | 30 Sep 2018 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.46%
|
589,116
|
$10,474,000 | — | 30 Sep 2018 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.45%
|
574,859
|
$10,221,000 | — | 30 Sep 2018 | |
| FMR LLC |
13F
|
Company |
0.44%
|
567,328
|
$10,087,000 | — | 30 Sep 2018 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.43%
|
549,580
|
$9,772,000 | — | 30 Sep 2018 | |
| S.c.a. Candriam |
13F
|
Individual |
0.4%
|
515,700
|
$9,169,000 | — | 30 Sep 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
441,666
|
$7,852,000 | — | 30 Sep 2018 | |
| Opaleye Management Inc. |
13F
|
Company |
0.29%
|
375,000
|
$6,667,000 | — | 30 Sep 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
373,246
|
$6,636,000 | — | 30 Sep 2018 | |
| NF Trinity Capital (Hong Kong) Ltd |
13F
|
Company |
0.28%
|
357,142
|
$6,350,000 | — | 30 Sep 2018 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.17%
|
219,000
|
$3,894,000 | — | 30 Sep 2018 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.17%
|
212,470
|
$3,778,000 | — | 30 Sep 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.15%
|
196,078
|
$3,486,000 | — | 30 Sep 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
192,559
|
$3,424,000 | — | 30 Sep 2018 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.14%
|
185,000
|
$3,289,000 | — | 30 Sep 2018 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.14%
|
184,130
|
$3,274,000 | — | 30 Sep 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
142,788
|
$2,539,000 | — | 30 Sep 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
124,918
|
$2,220,000 | — | 30 Sep 2018 | |
| Eversept Partners, LP |
13F
|
Company |
0.08%
|
100,295
|
$1,783,245 | — | 30 Sep 2018 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.08%
|
99,413
|
$1,768,000 | — | 30 Sep 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
73,000
|
$1,298,000 | — | 30 Sep 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.06%
|
72,723
|
$1,293,000 | — | 30 Sep 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.06%
|
72,166
|
$1,283,000 | — | 30 Sep 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
63,712
|
$1,132,000 | — | 30 Sep 2018 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
63,400
|
$1,127,000 | — | 30 Sep 2018 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.05%
|
60,414
|
$1,074,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
60,312
|
$1,072,000 | — | 30 Sep 2018 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.05%
|
60,000
|
$1,067,000 | — | 30 Sep 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
55,268
|
$983,000 | — | 30 Sep 2018 | |
| VHCP Management III, LLC |
13F
|
Company |
0.04%
|
50,290
|
$894,000 | — | 30 Sep 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.04%
|
49,242
|
$875,000 | — | 30 Sep 2018 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
48,000
|
$853,000 | — | 30 Sep 2018 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
47,527
|
$845,000 | — | 30 Sep 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
40,200
|
$715,000 | — | 30 Sep 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
38,637
|
$687,000 | — | 30 Sep 2018 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
36,800
|
$654,000 | — | 30 Sep 2018 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
31,815
|
$566,000 | — | 30 Sep 2018 | |
| VHCP Management II, LLC |
13F
|
Company |
0.02%
|
29,710
|
$528,000 | — | 30 Sep 2018 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
26,033
|
$463,000 | — | 30 Sep 2018 |
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q4 2018
As of 31 Dec 2018,
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,104,592 shares.
The largest 10 holders included
Cormorant Asset Management, LP, BlackRock Inc., Hillhouse Capital Advisors, Ltd., Sectoral Asset Management Inc, Hillhouse Capital Management, Ltd., venBio Partners LLC, Vanguard Group Inc, VICTORY CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP.
This page lists
95
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
79
Q4 2018 holders
95
Holder diff
16
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.